Stimulation of endothelial cells by doses of basic FGF-saporin that are lethal to smooth muscle cells

Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents

Volumn 3, Issue 3, 1996, Pages 155-163

  Biro, Sadatoshi ^a   Shrivastav, Shashi ^a   Yu, Zu Xi ^a   Lappi, Douglas A ^b   Baird, Andrew ^b   Casscells, Ward ^a,c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b Whittier Institute for Diabetes   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

atherosclerosis; endothelial cells; fibroblast growth factor; restenosis; smooth muscle cells

Indexed keywords

RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR;

ANIMAL CELL; ANIMAL TISSUE; AORTA; BALLOON; BLOOD VESSEL INJURY; CELL CULTURE; CELL DEATH; CELL DIVISION; CELL SPECIFICITY; CELL TYPE; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; ENDOTHELIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; RECEPTOR DENSITY; RECEPTOR UPREGULATION; RESTENOSIS; SERUM; SMOOTH MUSCLE FIBER;

EID: 0029836984     PISSN: 10717544     EISSN: None     Source Type: Journal    
DOI: 10.3109/10717549609029445     Document Type: Conference Paper

References (55)

1. Hermans, W. R. M., Rensing, B. J., Strauss, B. H., and Serruys, P. W. (1991) Prevention of restenosis after percutaneous transluminal coronary angioplasty: the search fora "magic bullet." Am. Heart J. 122, 171-187.
2. Ip, J. H., Fuster, V., Badimon, L., Badimon, J., Taubman, M. B., and Chesebro, J. H. (1990) Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J. Am. Cardiol. 15, 1667-1687.
3. Casscells, W. (1992) Migration of endothelial and smooth muscle cells: critical events in restenosis. Circulation 86, 723-729.
4. Schwartz, S. M., Heimark, R. L., and Majesky, M. W. (1990) Developmental mechanisms underlying pathology of arteries. Physiol. Rev. 70, 1177-1209.
5. Casscells, W. (1991) Smooth muscle cell growth factors. Prog. Growth Factor Res. 3, 177-206.
6. Thyberg, J., Hedin, U., Sjolund, M., Palmberg, L., and Bottger, B. A. (1990) Regulation of differentiated properties and proliferation of arterial smooth muscle cells. Arteriosclerosis 10, 966-990.
7. Baird, A., and Bohlen, P. (1990) Fibroblast growth factors. In Handbook of Experimental Pharmacology: Peptide Growth Factors and Their Receptors (Sporn, M. B., and Roberts, A. B., eds.), pp. 369-418, Springer, Berlin.
8. Gospodarowicz, D. (1989) Fibroblast growth factor. Crit. Rev. Oncogene 1, 1-26.
9. Baird, A., and Klagsbrun, M. (1991) The fibroblast growth factor family. Cancer Cells 3, 239-244.
10. Casscells, W., Wai, C., Shrivastav, S., Tanner, V. A., Fu, Y. M., Zu, Z. X., Gonzalez, A. M., Lappi, D. A., and Baird, A. (1990) Smooth muscle cell proliferation in vessel injury is characterized by expression of fibroblast growth factor receptors and is inhibited by a toxin-fibroblast growth factor conjugate. Circulation 82, III-825.
11. Langille, B. L., Bendeck, M. P., and Keeley, F. W. (1989) Adaptations of carotid arteries of young and mature rabbits to reduced carotid blood flow. Am. J. Physiol. 256, 931-939.
12. Serruys, P. N., Strauss, B. H., van Beuseken, H. M., and van der Gressen, W. J. (1991) Stenting of coronary arteries: has a modern Pandora's box been opened? J. Am. Coll. Cardiol. 17, 143B-154B.
13. Safian, R. D., Gelbfish, J. S., Erny, R. E., Schnitt, S. J., Schmidt, D. A., and Baim, D. S. (1990) Coronary atherectomy: clinical, angiographic, and histological findings and observations regarding potential mechanisms. Circulation 82, 69-79.
14. Ferns, G. A. A., Raines, E. W., Sprugel, K. H., Motani, A. S., Reidy, M. A., and Ross, R. (1991) Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 253, 1129-1132.
15. Waldmann, T. A. (1991) Monoclonal antibodies in diagnosis and therapy. Science 252, 1657-1662.
16. Vitetta, E., and Thorpe, P. E. (1992) Immunotoxins. In Biologic Therapy of Cancer: Principles and Practice (DeVita, V., Hellman, S., and Rosenberg, S., eds.), J. B. Lippincott, Philadelphia.
17. FitzGerald, D., and Pastan, I. (1989) Targeted toxin therapy for the treatment of cancer. J. Natl. Cancer Inst. 81, 1455-1463.
18. Casscells, W., Lappi, D. A., Olwin, B., Wai, C., Siegman, M., Speir, E. H., Sasse, J., and Baird, A. (1992) Elimination of smooth muscle cells in experimental restenosis: targeting of FGF receptors. Proc. Natl. Acad. Sci. USA 89, 7159-7163.
19. Lappi, D. A., Maher, P. A., Martineau, D., and Baird, A. (1991) The basic fibroblast growth factor-saporin mitotoxin acts through the basic fibroblast growth factor receptor. J. Cell. Physiol. 147, 17-26.
20. Speir, E., Sasse, J., Shrivastav, S., and Casscells, W. (1991) Culture-induced increase in acidic and basic fibroblast growth factor activities and their association with the nuclei of vascular endothelial and smooth muscle cells. J. Cell. Physiol. 147, 362-373.
21. Gown, A. M., Tsukada, T., and Ross, R. (1986) Human atherosclerosis: immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am. J. Pathol. 125, 191-207.
22. Voyta, J. C., Via, D. P., Butterfield, C. E., and Zetter, B. R. (1984) Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein. J. Cell Biol. 99, 2034-2040.
23. Moscatelli, D. (1987) High and low affinity binding sites for basic fibroblast growth factor on cultured cells: absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells. J. Cell. Physiol. 131, 123-130.
24. Olwin, B. B., and Hauschka, S. D. (1989) Cell type and tissue distribution of the fibroblast growth factor receptor. J. Cell Biochem. 39, 443-454.
25. Johnson, D. E., and Williams, L. T. (1993) Structural and functional diversity in the FGF receptor multigene family. Adv. Cancer Res. 60, 1-40.
26. Clowes, A. W., Reidy, M. A., and Clowes, M. M. (1983) Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Lab. Invest. 49, 327-333.
27. Casscells, W., Speir, E., Sasse, J., Klagsbrun, M., Allen, P., Lee, M., Calvo, B., Chiba, M., Haggroth, L., Folkman, J., and Epstein, S. E. (1990) Isolation, characterization and localization of heparin-binding growth factors in the heart. J. Clin. Invest. 85, 433-441.
28. Campbell, J. H., Kocher, O., Skalli, O., Gabbiani, G., and Campbell, G. R. (1989) Cytodifferentiation and expression of α-smooth muscle actin mRNA and protein during primary culture of aortic smooth muscle cells: correlation with cell density and proliferative state. Atherosclerosis 9, 633-643.
29. Baird, A., and Ling, N. (1987) Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells in vitro: implications for a role of heparinase-like enzymes in the neovascular response. Biochem. Biophys. Res. Commun. 142, 428-435.
30. Biro, S., Iino, T., Epstein, S. E., and Casscells, W. (1991) Adenosine does not regulate the proliferation of cultured capillary or coronary sinus endothelial cells. J. Vasc. Biol. Med. 3, 11-18.
31. Schweigerer, L., Neufeldt, G., Friedman, J., Abraham, J. A., Fiddes, J. C., and Gospodarowicz, D. (1987) Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth. Nature 325, 257-259.
32. Vlodavsky, I., Fridman, R., Sullivan, R., Sasse, J., and Klagsbrun, M. (1987) Aortic endothelial cells synthesize basic fibroblast growth factor which remains cell associated and platelet-derived growth factor which is secreted. J. Cell. Physiol. 131, 302-408.
33. Zimering, M. B., Brandi, M. L., deGrange, D. A., and Marx, S. J. (1990) Circulating fibroblast growth factor-like substance in familial multiple endocrine neoplasia type I. J. Clin. Endocrinol. Metab. 70, 149-154.
34. Iruela-Arispe, M. L., Bornstein, P., and Sage, H. (1991) Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro. Proc. Natl. Acad. Sci. USA 88, 5026-5030.
35. Majack, R. A., Goodman, L. V., and Dixit, V. M. (1988) Cell surface thrombospondin is functionally essential for vascular smooth muscle cell proliferation. J. Cell Biol. 106, 415-422.
36. Bell, L., and Madri, J. A. (1990) Influence of the angiotensin system on endothelial and smooth muscle cell migration. Am. J. Pathol. 137, 7-10.
37. Berk, B. C., Vekshtein, V., Gordon, H. M., and Tsuda, T. (1989) Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension 13, 305-314.
38. Geisterfer, A. A. T., Peach, M. J., and Owens, G. K. (1988) Angiotensin II induces hypertrophy, not hyperplasia of cultured rat aortic smooth muscle cells. Circ. Res. 62, 749-756.
39. Naftilan, A. J., Pratt, R. E., and Dzau, V. J. (1989) Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J. Clin. Invest. 83, 1419-1424.
40. Bell, L., and Madri, J. A. (1989) Effect of platelet factors on migration of cultured bovine aortic endothelial and smooth muscle cells. Circ. Res. 65, 1057-1065.
41. Maione, T. E., Gray, G. S., Petro, J., Hunt, A. J., Donner, A. L., Bauer, S. I., Carson, H. F., and Sharpe, R. J. (1990) Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science 247, 77-79.
42. Antonelli-Orlidge, A., Saunders, K. B., Smith, S. R., and D'Amore, P. A. (1989) An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes. Proc. Natl. Acad. Sci. USA 86, 4544-4548.
43. Baird, A., and Durkin, T. (1986) Inhibition of endothelial cell proliferation by type beta-transforming growth factor. Biochem. Biophys. Res. Commun. 138, 476-482.
44. Takehara, K., LeRoy, E. C., and Grotendorst, G. R. (1987) TGF-β inhibition of endothelial cell proliferation: Alteration of EGF binding and EGF-induced growth-regulatory (competence) gene expression. Cell 49, 415-422.
45. Assoian, R. K., and Sporn, M. B. (1986) TGFβ in human platelets: release during platelet degranulation and action on vascular smooth muscle cells. J. Cell Biol. 102, 1217-1223.
46. Majack, R. A. (1987) Beta-type transforming growth factor specifies organizational behavior in vascular smooth muscle cell cultures. J. Cell Biol. 105, 465-471.
47. Owens, G. K., Geisterfer, A. A. T., Yang, Y. W. H., and Komoriya, A. (1988) Transforming growth factor-β-induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells. J. Cell Biol. 107, 771-780.
48. Battegay, E. J., Raines, E. W., Seifert, R. A., Bowen-Pope, D. F., and Ross, R. (1990) TGF-β induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell 63, 515-524.
49. Merwin, J. R., Newman, W., Beall, L. D., Tucker, A., and Madri, J. (1991) Vascular cells respond differentially to transforming growth factors beta 1 and beta 2 in vitro. Am. J. Pathol. 138, 37-51.
50. Kojima, S., Harpel, P. C., and Rifkin, D. B. (1991) Lipoprotein(a) inhibits the generation of transforming growth factor β: an endogenous inhibitor of smooth muscle cell migration. J. Cell Biol. 113, 1439-1445.
51. Hoshi, H., Kan, M., Chen, J. K., and McKeehan, W. (1988) Comparative endocrinology-paracrinology-autocrinology of human adult large vessel endothelial and smooth muscle cells. In Vitro Cell Dev. Biol. 24, 309-320.
52. Zerwes, H. G., and Risau, W. (1987) Polarized secretion of a platelet-derived growth factor-like chemotactic factor by endothelial cells in vitro. J. Cell Biol. 105, 2037-2041.
53. Bar, R. S., Boes, M., Booth, B. A., Dake, B. L., Henley, S., and Hart, M. N. (1989) The effects of platelet-derived growth factor in cultured microvessel endothelial cells. Endocrinology 124, 1841-1848.
54. Beitz, J. G., Kim, I. S., Calabresi, P., and Frackelton, A. R., Jr. (1991) Human microvascular endothelial cells express receptors for platelet-derived growth factor. Proc. Natl. Acad. Sci. USA 88, 2021-2025.
55. Heldin, P., Pertoft, H., Nordlinder, H., Heldin, C. H., and Laurent, T. C. (1991) Differential expression of platelet-derived growth factor α- and β-receptors on fat-storing cells and endothelial cells of rat liver. Exp. Cell Res. 193, 364-369.